Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Vaccine and Treatment Evaluation Units (VTEUs)


What services does this resource provide?

The VTEUs, supported by the Division of Microbiology and Infectious Diseases (DMID) since the 1960s, comprise a consortium of individual contracts within academic centers and organizations that provide a ready resource for the conduct of clinical trials to evaluate promising vaccines and treatments for infectious diseases.

VTEUs conduct a broad range of studies including Phase I, Phase II, Phase III, and Phase IV clinical trials of bacterial, viral, and parasitic vaccines, therapeutics, and other biologics and drugs as preventive and therapeutic measures against infectious diseases in people of all ages and risk categories. VTEUs can also undertake a variety of other studies that support product development such as evaluations of novel investigational product delivery systems and reevaluation of current vaccine formulations and schedules of delivery. Some VTEU contract sites have established subcontracts with additional investigational sites.

Who provides the services?

There are nine current VTEU contract award sites.



Last Updated November 29, 2012